CEO SUMMARY: This will be one of the most challenging years facing the clinical lab industry since the early 1990s, when closed panel HMOs were the disruptive force that generated deep cuts in lab test prices. However, unlike HMOs of that era, the CMS scheme to collect private payer lab test prices and use that […]
Why PAMA May Be Poised to Disrupt Lab Industry
Federal law is about to have pernicious effects, including eroding the financial stability of many labs
- By Robert Michel
- > From the Volume XXVI No. 1 - January 14, 2019 Issue
- Tags: accountable care, Accountable care organizations, Anatomic pathology, blood brothers, clfs, clinical lab, clinical laboratories, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical laboratory market, clinical laboratory test, clinical labs, cms cuts, dark report, executive war college, hospital lab outreach programs, hospital laboratory, hospital laboratory outreach, lab industry, lab outreach, lab test, lab test prices, lab testing, lab testing services, lab tests, labcorp and quest, laboratories, laboratory fee schedule, laboratory organization, laboratory outreach, laboratory outreach program, laboratory services, laboratory test, Medicare, medicare lab, Medicare Part B, pathologists, pathology groups, pathology management, private payer, the clinical laboratory, the dark report
